Pharmaceutical distributors provide the medication for over 4.2 billion prescriptions annually in the U.S., but their role in the healthcare ecosystem has never been in the spotlight the way it is today. The COVID-19 pandemic is driving intense demand for fast, efficient distribution of pharma products.
Bob Mauch, EVP and Group President of AmerisourceBergen, said the global pandemic precipitated a 50 percent spike in demand, and resulted in “a great demonstration of the capabilities of the pharmaceutical supply chain.”
In this video interview, Fierce Pharma Publisher Rebecca Willumson talks with Mauch and with Chip Davis, President and CEO of Healthcare Distribution Alliance, about the impact of the pandemic on the pharmaceutical supply chain, the value of pharma distributors, and how the role of distributors is evolving in a dynamic marketplace.
Hear more from Mauch and Davis in this interview with Fierce Pharma. If you’d like more information, visit www.amerisourcebergen.com.